Skip to main content

Table 1 Patient demographic data

From: Efficacy and safety of 5-fluorouracil in infrared monitor guided bleb revision

  With 5-FU Needle Revision Group (n = 30) Without 5-FU Needle Revision Group (n = 13) P Value
Sex    0.48*
 Men 15 (51.7%) 7 (63.6%)  
 Women 14 (48.3%) 4 (36.4%)  
Age at needling (years) 61.0 ± 16.2 63.8 ± 13.5 0.68†
Disease    0.75*
 Primary open-angle glaucoma 9 (30%) 5 (38.5%)  
 Secondary glaucoma 21 (70%) 8 (61.5%)  
 Neovascular glaucoma 2 (6.7%) 0  
 Exfoliation glaucoma 6 (20%) 0  
 Uveitis 4 (13.3%) 4 (30.8%)  
 Others 9 (30%) 4 (30.8%)  
Previous intraocular surgery 1.4 ± 1.33 1.0 ± 1.44 0.28†
Time between previous trabeculectomy and needling (days) 767.8 ± 898.9 890.2 ± 1448.0 0.30†
 〜6 months 14 (46.7%) 8 (61.5%)  
 6 months 〜 2 years 5 (16.7%) 1 (7.7%)  
 2 years 〜 11 (36.7%) 4 (30.8%)  
IOP pre-needling (mmHg) 28.9 ± 9.3 26.6 ± 9.6 0.28†
Score of glaucoma medications pre-needling (point) 2.5 ± 2.0 2.0 ± 2.1 0.38†
  1. 2 test
  2. †Wilcoxon rank test
  3. 5-FU, 5-fluorouracil; IOP, intraocular pressure
\